BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2827566)

  • 1. Antiviral activity and inhibition of topoisomerase by ofloxacin, a new quinolone derivative.
    Ikeda S; Yazawa M; Nishimura C
    Antiviral Res; 1987 Oct; 8(3):103-13. PubMed ID: 2827566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs.
    Ikeda S; Negishi T; Nishimura C
    Antiviral Res; 1985 Aug; 5(4):207-15. PubMed ID: 2412489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiviral properties of fucidin].
    Goncharskaia TIa; Navashin SM
    Antibiotiki; 1971 Jan; 16(1):57-60. PubMed ID: 4324189
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ATP and inhibitory factors on the activity of vaccinia virus type I topoisomerase.
    Foglesong PD; Bauer WR
    J Virol; 1984 Jan; 49(1):1-8. PubMed ID: 6317884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice.
    Neyts J; De Clercq E
    Antimicrob Agents Chemother; 2001 Jan; 45(1):84-7. PubMed ID: 11120949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acyl substituents of synthetic lipid A-subunit analogues on their immunomodulating antiviral activity.
    Ikeda S; Nishimura C; Matsuura M; Homma JY; Kiso M; Hasegawa A
    Antiviral Res; 1990 Jun; 13(6):327-33. PubMed ID: 1699495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of ofloxacin and its mode of action.
    Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
    Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
    Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-herpes simplex virus effect of an aqueous extract of propolis.
    Huleihel M; Isanu V
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):923-7. PubMed ID: 12455181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attempt at treatment with methisazone of an infant with vaccinia and herpes simplex viruses].
    Jankowska H
    Przegl Epidemiol; 1970; 24(1):119-21. PubMed ID: 4317266
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus.
    De Clercq E; Descamps J; Verhelst G; Walker RT; Jones AS; Torrence PF; Shugar D
    J Infect Dis; 1980 May; 141(5):563-74. PubMed ID: 6246180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral and cytotoxic effects of mycophenolic acid.
    Planterose DN
    J Gen Virol; 1969 Jun; 4(4):629-30. PubMed ID: 4308492
    [No Abstract]   [Full Text] [Related]  

  • 14. On the antiviral activity of diffusomycin (oxazolomycin).
    Tonew E; Tonew M; Gräfe U; Zöpel P
    Acta Virol; 1992 Mar; 36(2):166-72. PubMed ID: 1359768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiviral activity of some related benzo(b)thiophene derivatives. I. Initial screening tests.
    Boyd JE; Sommerville RG
    Arch Gesamte Virusforsch; 1974; 45(3):249-53. PubMed ID: 4370660
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactivation of human immunodeficiency, herpes simplex, and vaccinia viruses by sodium oxychlorosene.
    Klein RJ; Buimovici-Klein E; Ong KR; Czelusniak SM; Lange M; Friedman-Kien AE
    Lancet; 1987 Jan; 1(8527):281-2. PubMed ID: 2880106
    [No Abstract]   [Full Text] [Related]  

  • 18. International experiences with ofloxacin, a new quinolone.
    Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of novobiocin and other DNA gyrase inhibitors on virus replication and DNA synthesis in herpes simplex virus type 1-infected BHK cells.
    Francke B; Margolin J
    J Gen Virol; 1981 Feb; 52(Pt 2):401-4. PubMed ID: 6270241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.